PMID: 3760015Sep 1, 1986Paper

Profunda femoris revascularization in limb salvage

The Journal of Cardiovascular Surgery
K Miksic, B Novak

Abstract

A retrospective study of 282 profunda femoris artery reconstructions between 1971 and 1981 with follow-up at least two years in 212 (75.1%) is presented. Arteriographic evaluation was performed in 92 cases. Stages III and IV were the indication for revascularization in 86% of cases. An inflow correction was necessary in 60.3% of profunda reconstructions. Factors that bear on the success or failure of profundaplasty were evaluated. These were aorto-iliac inflow, the extent of disease in the profunda femoris artery, the run-off in the distal popliteal-tibial system and the extent of the ischemic lesion. Of the failures most were due to established gangrene, obstructions throughout the whole length of the profunda or patients with a poor popliteal-tibial run-off system. The cumulative limb salvage at two years was 86.8% in limbs subjected to inflow correction procedure and profundaplasty but only in 56.5% of repair of the profunda alone. In the majority of the below-knee amputations after profundaplasty, repair of the profunda was used to lower the level of amputation from above knee to below the knee. Profundaplasty is worth considering even in those patients who cannot be offered other revascularization surgery.

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.